Table 1 Baseline characteristics of the subjects who completed screening over 3 visits and started on ART and those who did not
Completed 3 screening visits and started ART | Odds ratio (95% CI) for not completing screening | |||
|---|---|---|---|---|
No (n. 637) | Yes (n. 1846) | Univariate | Multivariate * | |
Men | 211 (29) | 520 (71) | 1.26 (1.04, 1.54) | 1.28 (1.05, 1.56) |
women | 426 (24) | 1,326 (76) | 1.0 | 1.0 |
(p = 0.02) | (p = 0.02) | |||
Age, years | ||||
<33 | 213 (28) | 538 (72) | 1.23 (0.98, 1.53) | 1.20 (0.95, 1.51) |
33–39 | 183 (25) | 561 (75) | 1.01 (0.81, 1.27) | 1.22 (0.98, 1.53) |
≥ 40 | 241 (24) | 747 (76) | 1.0 | 1.0 |
(p = 0.1) | (p = 0.2) | |||
CD4 count × 106/l | ||||
<50 | 232 (32) | 485 (68) | 1.72 (1.40, 2.12) | 1.31 (1.0, 1.71) |
50–99 | 114 (27) | 314 (73) | 1.31(1.01, 1.69) | 1.68 (1.37, 2.06) |
≥100 | 291 (22) | 1047 (78) | 1.0 | 1.0 |
(p < 0.0001) | (p < 0.001) | |||
WHO stage | n = 628 | n = 1842 | ||
I, II | 265 (24) | 830 (76) | 0.89 (0.74, 1.07) | - |
III, IV | 363 (26) | 1,012 (74) | 1.0 | |